hsa_circRNA_405498与hsa_circRNA_100033可作为1型糖尿病鉴别诊断的潜在生物标志物
研究通过微阵列筛选1型糖尿病(T1D)差异表达的环状RNA,并在包含T1D、T2D、LADA及对照的457人队列中用LASSO回归评估诊断效能。hsa_circRNA_405498和hsa_circRNA_100033在T1D中显著下调,两者联合临床参数的模型区分T1D与LADA、T2D及对照的AUC分别为0.915、0.993和0.992。
要点
- hsa_circRNA_405498和hsa_circRNA_100033在T1D中较对照显著下调(均P<.05)。
- 两circRNA表达从对照、T2D、LADA到T1D呈序贯性下调(P<.05)。
- 两circRNA联合临床参数模型鉴别T1D与LADA的AUC=0.915。
核心结论
- hsa_circRNA_405498和hsa_circRNA_100033是T1D有前景的新型鉴别诊断生物标志物。
研究设计与样本
- 采用Arraystar人类circRNA微阵列在T1D与对照(各n=6)中测定circRNA表达谱。
- 用实时定量聚合酶链反应在20例T1D和20例对照的验证队列中验证差异表达circRNA。
- 在包含T1D、T2D、LADA患者及对照的457人较大队列中,用逻辑LASSO回归模型评估候选circRNA和临床参数的诊断效能。
主要发现
- 在T1D患者与对照比较中鉴定出110个差异表达的环状转录本(53个上调、57个下调)。
- hsa_circRNA_405498和hsa_circRNA_100033水平在T1D中较对照显著下调(均P<.05)。
- 两circRNA表达水平从对照、T2D、LADA到T1D呈序贯性下调(P<.05)。
- 逻辑LASSO回归模型ROC曲线AUC显示,两circRNA联合部分临床参数的组合模型区分T1D与LADA的AUC=0.915,区分T1D与T2D的AUC=0.993,区分T1D与对照的AUC=0.992。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The role of circular RNAs (circRNAs) in type 1 diabetes (T1D) is largely unknown. OBJECTIVE: We aimed to identify some circRNAs as differential diagnostic biomarkers for T1D to distinguish between patients with latent autoimmune diabetes in adults (LADA) and type 2 diabetes (T2D). METHODS: The circRNA expression profiles were determined by Arraystar human circRNA microarray in T1D compared to controls (n = 6 each). The differentially expressed circRNAs were validated by real-time quantitative polymerase chain reaction using a validation cohort with 20 T1D and 20 controls. The diagnostic performances of the candidate circRNAs and the clinical parameters were assessed using the logistic least absolute shrinkage and selection operator (LASSO) regression model in a larger cohort with 457 individuals, including patients with T1D, T2D, and LADA, and controls. RESULTS: We identified 110 differentially expressed circular transcripts (53 upregulated and 57 downregulated) in T1D patients compared with controls. Further analysis showed that the levels of hsa_circRNA_405498 and hsa_circRNA_100033 were significantly downregulated in T1D compared to controls (both P < .05). Moreover, the expression levels of these 2 circRNAs showed sequential downregulation from controls, patients with T2D, LADA, to T1D (P < .05). The area under the curve (AUC) of receiver operating characteristic plots in logistic LASSO regression model showed high diagnostic accuracy for combination model with the 2 circRNAs and some clinical parameters in distinguishing T1D from LADA (AUC = 0.915), T2D (AUC = 0.993), and controls (AUC = 0.992). CONCLUSION: Our study demonstrated that hsa_circRNA_405498 and hsa_circRNA_100033 are promising novel differential diagnostic biomarkers for T1D.
引用
- Zhang Z, Luo S, Xiao Z, et al. Hsa_circRNA_405498 and hsa_circRNA_100033 Serve as Potential Biomarkers for Differential Diagnosis of Type 1 Diabetes. J Clin Endocrinol Metab. 2024. PMID: 38157408. doi:10.1210/clinem/dgad761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。